Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology


GÖRENEK B., Halvorsen S., Kudaiberdieva G., Bueno H., Van Gelder I. C., Lettino M., ...More

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, vol.9, no.4, pp.348-357, 2020 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 9 Issue: 4
  • Publication Date: 2020
  • Doi Number: 10.1177/2048872619894255
  • Journal Name: EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Page Numbers: pp.348-357
  • Keywords: Atrial fibrillation, acute heart failure, rate control, rhythm control, catheter ablation, pacing, risk of stroke, bleeding risk, anticoagulation, 2016 ESC GUIDELINES, DIGOXIN USE, CATHETER ABLATION, SINUS RHYTHM, OUTCOMES, WARFARIN, STROKE, RISK, PREVENTION, MANAGEMENT
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

Atrial fibrillation and acute heart failure frequently co-exist and can exacerbate each other. Their combination leads to increased morbidity and mortality. However, the prevalence and significance, as well as the treatment, of atrial fibrillation in acute heart failure are not well studied. Management of atrial fibrillation in acute heart failure requires a multidisciplinary team approach. Treatment of underlying disease(s), identification and treatment of potentially correctable causes and precipitating factors and anticoagulation are crucial. In this article, current evidence on atrial fibrillation in the setting of acute heart failure is summarised. The recommendations on management of atrial fibrillation in the prehospital stage, the treatment of reversible causes, when and how to use rate or rhythm control, maintenance of sinus rhythm, catheter ablation and pacing, anticoagulation, as well as measures on prevention of atrial fibrillation are provided.